IPO Update: High-Flying Biopharma IPOs Average 77.1% Return Through Q2

 
• By Mandy Jackson
businessman hand holding dollar plane with IPO text ,business idea , business concept, analysis concept
High-flying IPO returns ranged from -33.1% for Ayala to +438.6% for Schrodinger • Source: Shutterstock

More from Financing

More from Business